Pancreatic Cancer Research

ResearcherAnhui Medical UniversityNo recent work listed

Fei Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2340-5644; OpenAlex author ID A5113371339. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance. Co-author DOI 10.1136/jitc-2023-006698↗
  2. Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. First author DOI 10.3892/ol.2019.10627↗
  3. Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells. Last author DOI 10.3892/or.2018.6450↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yue Yu · 2 shared papers, 2018–2019 · strength 0.26
  2. Yesiboli Tasiheng · 1 shared paper, 2023 · strength 0.15
  3. Mingjian Ma · 1 shared paper, 2023 · strength 0.15
  4. Yusheng Chen · 1 shared paper, 2023 · strength 0.15
  5. Xu Wang · 1 shared paper, 2023 · strength 0.15
  6. He Cheng · 1 shared paper, 2023 · strength 0.15
  7. Xuan Lin · 1 shared paper, 2023 · strength 0.15
  8. Zhengjie Dai · 1 shared paper, 2023 · strength 0.15
  9. Xuan Zou · 1 shared paper, 2023 · strength 0.15
  10. Yu Yan · 1 shared paper, 2023 · strength 0.15
  11. Xianjun Yu · 1 shared paper, 2023 · strength 0.15
  12. Chen Liu · 1 shared paper, 2023 · strength 0.15
  13. Chao Xu · 1 shared paper, 2018 · strength 0.14
  14. Le Ren · 1 shared paper, 2019 · strength 0.12
  15. Meng Gao · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.